scispace - formally typeset
C

Caroline Delmas

Researcher at French Institute of Health and Medical Research

Publications -  34
Citations -  1328

Caroline Delmas is an academic researcher from French Institute of Health and Medical Research. The author has contributed to research in topics: Radioresistance & RHOB. The author has an hindex of 18, co-authored 30 publications receiving 1116 citations. Previous affiliations of Caroline Delmas include Paul Sabatier University & University of Toulouse.

Papers
More filters
Journal ArticleDOI

Alphavbeta3 and alphavbeta5 integrins control glioma cell response to ionising radiation through ILK and RhoB.

TL;DR: In this paper, the role of integrin activation and integrin signalling pathways controlled the glioma cell radiosensitivity to ionizing radiation, which was mediated through the integrin-linked kinase, ILK, and the small GTPase, RhoB.
Journal ArticleDOI

αvβ3/αvβ5 Integrins-FAK-RhoB: A Novel Pathway for Hypoxia Regulation in Glioblastoma

TL;DR: The present results unravel a new mechanism of hypoxia regulation by establishing the existence of an alpha(v)beta(3) and alpha( v) beta(5) integrin-dependent loop of Hypoxia autoregulation in glioma, which may be crucial to optimizing radiotherapy efficiency.
Journal ArticleDOI

Farnesyltransferase inhibitor, R115777, reverses the resistance of human glioma cell lines to ionizing radiation.

TL;DR: It is demonstrated that RhoB, but not Ras, is implicated in glioma radioresistance, and the R115777 differential radiosensitizer effect underlines the potential therapeutic interest of using this drug as a radiosensitizeder of humanglioma.
Journal ArticleDOI

Activation of RhoB by Hypoxia Controls Hypoxia-Inducible Factor-1α Stabilization through Glycogen Synthase Kinase-3 in U87 Glioblastoma Cells

TL;DR: The results have shown the early activation of RhoB by reactive oxygen species under hypoxic conditions and, subsequently, its participation in the ensuing cellular adaptation to hypoxia, and strongly implicate Rho B as a potentially important therapeutic target for decreasing tumor Hypoxia.